Market closed
OmniAb/$OABI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OmniAb
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
Ticker
$OABI
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
114
Website
OmniAb Metrics
BasicAdvanced
$189M
-
-$0.61
0.35
-
Price and volume
Market cap
$189M
Beta
0.35
52-week high
$3.54
52-week low
$1.54
Average daily volume
1.1M
Financial strength
Current ratio
4.516
Quick ratio
4.289
Long term debt to equity
6.739
Total debt to equity
8.054
Management effectiveness
Return on assets (TTM)
-13.29%
Return on equity (TTM)
-20.60%
Valuation
Price to revenue (TTM)
6.012
Price to book
0.66
Price to tangible book (TTM)
2.87
Price to free cash flow (TTM)
-3.82
Growth
Revenue change (TTM)
-22.75%
Earnings per share change (TTM)
19.34%
3-year revenue growth (CAGR)
-8.76%
3-year earnings per share growth (CAGR)
22.79%
OmniAb News
AllArticlesVideos
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
GlobeNewsWire·2 days ago
OmniAb Announces Two New Appointments to its Board of Directors
Business Wire·2 weeks ago
OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for OmniAb stock?
OmniAb (OABI) has a market cap of $189M as of May 07, 2025.
What is the P/E ratio for OmniAb stock?
The price to earnings (P/E) ratio for OmniAb (OABI) stock is 0 as of May 07, 2025.
Does OmniAb stock pay dividends?
No, OmniAb (OABI) stock does not pay dividends to its shareholders as of May 07, 2025.
When is the next OmniAb dividend payment date?
OmniAb (OABI) stock does not pay dividends to its shareholders.
What is the beta indicator for OmniAb?
OmniAb (OABI) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.